MELISSA PASCHALL: Open Payments
NPI 1851834238 · HENRICO, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,893 in 194 payments from 18 companies in 2025. Trend: 2023 $2,300 · 2024 $2,988 · 2025 $3,893
Food & beverage: $3,622Education: $271
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $538 |
| ABBVIE INC. | 20 | $421 |
| LEO Pharma Inc. | 20 | $339 |
| UCB, Inc. | 16 | $315 |
| Regeneron Healthcare Solutions, Inc. | 10 | $285 |
| Novartis Pharmaceuticals Corporation | 14 | $271 |
| Amgen Inc. | 10 | $249 |
| GENZYME CORPORATION | 8 | $206 |
| Lilly USA, LLC | 8 | $189 |
| Galderma Laboratories, L.P. | 22 | $188 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Bimzelx, ADBRY, OTEZLA, NEMLUVIO, EBGLYSS.
Industry payments across VA — which companies pay providers there.
